EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial

Keun Ju Kim iD, Young Kyung Yoon, Jeong Yeon Kim iD, Min Ja Kim, Jang Wook Sohn, Myung Hyun Nam iD

Clinical Infectious Diseases · 20.08.2026

DOI: 10.1093/cid/ciag511 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 20.08.2026. Verfasst von Keun Ju Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: bioMérieux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapid identification of pathogens and antimicrobial resistance is important for optimizing therapies for bloodstream infections. We conducted a randomized controlled trial comparing standard of care (SOC) culture and phenotypic antimicrobial susceptibility testing with SOC plus BioFire BCID2 testing (Multiplex PCR arm).

Methods

Patients with positive blood cultures were randomized 1:1 to the SOC or multiplex PCR arm, both with antimicrobial stewardship. The primary outcome was the time from randomization to the first effective antimicrobial modification within 120 hours. The secondary outcomes were persistent bloodstream infections, mortality, and length of hospital stay.

Results

Among 418 patients (208 SOC, 210 multiplex PCR), the median time to first effective antimicrobial modification was significantly shorter in the multiplex PCR arm (23.2 vs 64.5 hours; P < .001). This was consistent across Gram-negative (30.5 vs 77.1 hour; P < .001), Gram-positive (22.7 vs 53.5 hours; P = .001), and yeast infections (2.9 vs 27.7 hours; P < .001). The reduction was maintained regardless of laboratory hours (regular hours: 9.3 vs 66.7 hours; off-hours: 37.5 vs 60.5 hours; P < .001) and intensive care unit (ICU) status (ICU: 20.5 vs 84.8 hours; P < .001; non-ICU: 23.4 vs 55.5 hours; P < .001). The multiplex PCR arm showed a lower rate of persistent bloodstream infections (5.7% vs 11.5%, P = .038). No significant differences were observed in 30-day mortality or length of stay.

Conclusions

Rapid multiplex PCR shortened the time to effective antimicrobial modification in patients with bloodstream infections.

Schlagwörter

Stichwörter der Autor:innen

Blood culturesPCRantimicrobial resistancebloodstream infectionrapid diagnostics

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Division of Infectious Diseases, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Keun Ju Kim, Jeong Yeon Kim, Myung Hyun Nam

Förderung

  • bioMérieux

Zitieren

APA

Kim, K. J., Yoon, Y. K., Kim, J. Y., Kim, M. J., Sohn, J. W., & Nam, M. H. (2026). Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag511

Vancouver

Kim KJ, Yoon YK, Kim JY, Kim MJ, Sohn JW, Nam MH. Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag511

BibTeX
@article{Kim2026,
  author = {Kim, Keun Ju and Yoon, Young Kyung and Kim, Jeong Yeon and Kim, Min Ja and Sohn, Jang Wook and Nam, Myung Hyun},
  title = {Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag511}
}
Kostenlos starten →